Stay updated with breaking news from Epic Sciences Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global cancer stem cells market expected to grow by 2026 due to rising prevalence of cancer. The breast cancer sub-segment is expected to be highly profitable. Market in the North America
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...
/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...
/PRNewswire/ -- The Breast Cancer Liquid Biopsy Market size is expected to grow by USD 464.12 million from 2021 to 2026, at a CAGR of 16.35% during the...